Imatinib Impedes EMT and Notch signaling by Inhibiting p300 Acetyltransferase in Breast Cancer Cells

Scientists highlighted the ability of Imatinib to suppress epithelial-mesenchymal transition through modulation of the Notch signaling pathway, offering a novel therapeutic avenue for breast cancer treatment.